Critical Care

official impact factor 4.60

Open Access Highly Access Research

Tirofiban preserves platelet loss during continuous renal replacement therapy in a randomised prospective open-blinded pilot study

Andreas Link*, Matthias Girndt, Simina Selejan, Ranja Rbah and Michael Böhm

Critical Care 2008, 12:R111 doi:10.1186/cc6998


See related commentary by Storm and Jörres, http://ccforum.com/content/12/6/193

No comments have yet been made on this article.

Post a comment